Home > Insider Trading > Filing (0001209191-22-040356)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1806310	Taysha Gene Therapies Inc.	TSHA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1679129	Suyash Prasad	C/O Taysha Gene Therapies, Inc. 3000 Pegasus Park Drive, Ste 1430 Dallas TX 75247	Cmo And Head Of R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2022-06-29	12,324	$3.81	581,265	No	4	S	Direct
Common Stock	Disposition	2022-06-30	13,892	$3.72	567,373	No	4	S	Direct
Common Stock	Disposition	2022-07-01	23,923	$3.53	543,450	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.64 to $3.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.65 to $3.81, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.41 to $3.82, inclusive.